Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 55 (12%) | |
Anticipated shortage: | 14 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
13 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 1MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135436 |
TERAZOSIN | 2MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135430 |
TERAZOSIN | 5MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135433 |
TERAZOSIN | 10MG | TABLET | Resolved | 2017-09-27 | 2017-10-07 | 23666 |
TERAZOSIN | 10MG | TABLET | Resolved | 2018-06-28 | 2018-10-13 | 53076 |
TERAZOSIN | 10MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135439 |
NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-25 | 2018-12-11 | 56416 |
NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-05-16 | 2018-08-16 | 49537 |
MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2020-06-03 | 100024 |
MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100028 |
MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-29 | 2024-03-02 | 100031 |
LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-08-02 | 2020-02-27 | 17964 |
LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
FAMOTIDINE | 20MG | TABLET | Resolved | 2019-10-01 | 2020-04-29 | 95094 |
FAMOTIDINE | 20MG | TABLET | Resolved | 2020-10-29 | 2024-03-02 | 127488 |
FAMOTIDINE | 40MG | TABLET | Resolved | 2019-10-01 | 2020-04-29 | 95100 |
FAMOTIDINE | 40MG | TABLET | Resolved | 2020-10-29 | 2020-12-11 | 127491 |
FAMOTIDINE | 40MG | TABLET | Resolved | 2021-08-12 | 2024-03-02 | 144050 |
FUROSEMIDE | 20MG | TABLET | Resolved | 2023-03-16 | 2023-07-06 | 187311 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |
DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |